p130Cas substrate domain signaling promotes migration, invasion, and survival of estrogen receptor-negative breast cancer cells

QR Code

p130Cas substrate domain signaling promotes migration, invasion, and survival of estrogen receptor-negative breast cancer cells

Anna C Cunningham-Edmondson1,2, Steven K Hanks11Department of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, TN, USA; 2Department of Cellular Biology and Anatomy, Medical College of Georgia, Augusta, GA, USAAbstract: Elevated Src tyrosine kinase activity is comm...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Anna C Cunningham-Edmondson, Steven K Hanks
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2009
Sujets:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Accès en ligne:	https://doaj.org/article/5bcf7b4d79a54bf8ac44e71757d8a5bf
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Extra-nuclear signalling of estrogen receptor to breast cancer cytoskeletal remodelling, migration and invasion.
par: Maria Silvia Giretti, et autres
Publié: (2008)

Dysregulation of Blimp1 transcriptional repressor unleashes p130Cas/ErbB2 breast cancer invasion
par: Marianna Sciortino, et autres
Publié: (2017)

Author Correction: The miR-24-3p/p130Cas: a novel axis regulating the migration and invasion of cancer cells
par: Hoin Kang, et autres
Publié: (2021)

Survival rates of advanced estrogen-receptor positive breast cancer. Analysis of 211 cases
par: Sánchez,César, et autres
Publié: (2020)

The actin cytoskeletal architecture of estrogen receptor positive breast cancer cells suppresses invasion
par: Marco Padilla-Rodriguez, et autres
Publié: (2018)

Profiling of gene expression regulated by 17β-estradiol and tamoxifen in estrogen receptor-positive and estrogen receptor-negative human breast cancer cell lines
par: Rangel N, et autres
Publié: (2017)

MicroRNA- 130b suppresses migration and invasion of colorectal cancer cells through downregulation of integrin β1 [corrected].
par: Yanyang Zhao, et autres
Publié: (2014)

Lymphovascular invasion, race, and the 21-gene recurrence score in early estrogen receptor-positive breast cancer
par: Della Makower, et autres
Publié: (2021)

Estradiol analogs attenuate autophagy, cell migration and invasion by direct and selective inhibition of TRPML1, independent of estrogen receptors
par: Philipp Rühl, et autres
Publié: (2021)

Impact of clinical targeted sequencing on endocrine responsiveness in estrogen receptor-positive, HER2-negative metastatic breast cancer
par: Kanako Hagio, et autres
Publié: (2021)

Positive Regulation of Estrogen Receptor Alpha in Breast Tumorigenesis
par: Lucas Porras, et autres
Publié: (2021)

Acta No. 130
par: Banco Central de Chile
Publié: (2019)

Impact of estrogen receptor levels on outcome in non-metastatic triple negative breast cancer patients treated with neoadjuvant/adjuvant chemotherapy
par: Maria Vittoria Dieci, et autres
Publié: (2021)

Protein expression profile and microRNA expression signature in estrogen receptor-positive and -negative breast cancers: report of two cases
par: Tsunoda Y, et autres
Publié: (2018)

The Nek2 centrosome-mitotic kinase contributes to the mesenchymal state, cell invasion, and migration of triple-negative breast cancer cells
par: Yainyrette Rivera-Rivera, et autres
Publié: (2021)

Resolución 130(VII): Energía nuclear = Resolution 130(VII): Nuclear energy = Résolution 130(VII): Energie nucléaire
Publié: (2014)

Efficacy and safety of palbociclib and ribociclib in patients with estrogen and/or progesterone receptor positive, HER2 receptor negative metastatic breast cancer in routine clinical practice.
par: Sushmita Rath, et autres
Publié: (2021)

CEPAL Review no. 130
Publié: (2020)

Revista CEPAL no. 130
Publié: (2020)

Prolyl hydroxylase substrate adenylosuccinate lyase is an oncogenic driver in triple negative breast cancer
par: Giada Zurlo, et autres
Publié: (2019)

Estrogen receptor (ER) and progesterone receptor (PgR) in breast cancer of Indian women
par: Patil AV, et autres
Publié: (2011)

Single-cell immunoblotting resolves estrogen receptor-α isoforms in breast cancer.
par: John J Kim, et autres
Publié: (2021)

Resistance to CDK4/6 Inhibitors in Estrogen Receptor-Positive Breast Cancer
par: Erin R. Scheidemann, et autres
Publié: (2021)

Aromatase inhibition remodels the clonal architecture of estrogen-receptor-positive breast cancers
par: Christopher A. Miller, et autres
Publié: (2016)

The frequency and spectrum of PIK3CA mutations in patients with estrogen receptor-positive HER2-negative advanced breast cancer residing in various regions of Russia
par: Tatiana N. Sokolova, et autres
Publié: (2021)

RNF208, an estrogen-inducible E3 ligase, targets soluble Vimentin to suppress metastasis in triple-negative breast cancers
par: Kyoungwha Pang, et autres
Publié: (2019)

p130Cas Is Correlated with EREG Expression and a Prognostic Factor Depending on Colorectal Cancer Stage and Localization Reducing FOLFIRI Efficacy
par: Jörg Kumbrink, et autres
Publié: (2021)

Heparanase: a potential marker of worse prognosis in estrogen receptor-positive breast cancer
par: Tamar Zahavi, et autres
Publié: (2021)

Tumor suppressor ING4 inhibits estrogen receptor activity in breast cancer cells
par: Keenen MM, et autres
Publié: (2016)

Effect of Clinical and Treatment Factors on Survival Outcomes of Triple Negative Breast Cancer Patients
par: Wen S, et autres
Publié: (2020)

Systematic integrated analyses of methylomic and transcriptomic impacts of early combined botanicals on estrogen receptor-negative mammary cancer
par: Itika Arora, et autres
Publié: (2021)

Luteolin inhibits lung metastasis, cell migration, and viability of triple-negative breast cancer cells
par: Cook MT, et autres
Publié: (2016)

Crossover effects of estrogen receptor status on breast cancer-specific hazard rates by age and race.
par: Yu Ren, et autres
Publié: (2014)

The effects of black cohosh on the regulation of estrogen receptor (ERα) and progesterone receptor (PR) in breast cancer cells
par: Szmyd M, et autres
Publié: (2018)

Cytochrome 4Z1 Expression is Associated with Unfavorable Survival in Triple-Negative Breast Cancers
par: Al-saraireh YM, et autres
Publié: (2021)

Adipogenesis in triple-negative breast cancer is associated with unfavorable tumor immune microenvironment and with worse survival
par: Masanori Oshi, et autres
Publié: (2021)

Estrogens induce expression of membrane-associated estrogen receptor α isoforms in lactotropes.
par: Sandra Zárate, et autres
Publié: (2012)

HIG1 domain family member 1A disrupts proliferation, migration and invasion of colon adenocarcinoma cells
par: Zhenyu Xu, et autres
Publié: (2021)

Tudor Domain Containing Protein 3 Promotes Tumorigenesis and Invasive Capacity of Breast Cancer Cells
par: Alan Morettin, et autres
Publié: (2017)

Multidomain architecture of estrogen receptor reveals interfacial cross-talk between its DNA-binding and ligand-binding domains
par: Wei Huang, et autres
Publié: (2018)